The epidemic of coronavirus have significantly increased the efforts of scientists to create new, more effective drugs and devices. One of the newest Russian developments inhaler PM&HM. As the press service of the Russian venture company, the “area of defeat” will cover a number of serious diseases, including – very importantly – coronavirus pneumonia.
A serious drawback of the existing inhalers – very limited radius of action: up to 65% of the medicinal aerosol may not reach the source of inflammation, settling in the upper respiratory tract or tube device.
In contrast, new inhaler injects the aerosol before inhalation of the user, making the drug virtually without losses is delivered to the “address” to the patient body.
Currently, the device is tested to obtain the necessary certificate. In the future, the inhalers will go to public health facilities. They also can be purchased in individual use at a price of 3000 rubles.
Source — RVC